Tangkijvanich P - Search Results

1

Angptl4 integrates dietary and microbial signals to disrupt gut barrier function in MASH.

Chua D, Low ZS, Kim JHS, Lee YH, Kiatbumrung R, Somnark P, Xu M, Shi Y, Kaushal G, Vos MIG, Mahadevan A, Hooi N, Raj M, Sviriaeva E, Cui B, Tan S, Kasahara K, Ho CL, Wahli W, Yew KC, Wong SH, Cheung C, Pal M, Zhang R, Chuaypen N, Tangkijvanich P, Cheng HS, Li L, Tan NS. Chua D, et al. Among authors: tangkijvanich p. Nat Commun. 2026 May 22. doi: 10.1038/s41467-026-72575-6. Online ahead of print. Nat Commun. 2026. PMID: 42173835 Free article.

2

Utility of Biomarker Panels in the Surveillance and Monitoring of Hepatocellular Carcinoma: Consensus Statements from an International Delphi Panel.

Singal AG, Toyoda H, Tanwandee T, Tangkijvanich P, Tan CK, Cua IH, Alcantara-Payawal D, Su TH, Huy NDS, Yamada H, Kudo M. Singal AG, et al. Among authors: tangkijvanich p. Liver Cancer. 2025 Dec 19. doi: 10.1159/000550100. Online ahead of print. Liver Cancer. 2025. PMID: 41624065 Free PMC article.

3

Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study.

Brouwer WP, Chan HLY, Lampertico P, Hou J, Tangkijvanich P, Reesink HW, Zhang W, Mangia A, Tanwandee T, Montalto G, Simon K, Ormeci N, Chen L, Tabak F, Gunsar F, Flisiak R, Ferenci P, Akdogan M, Akyuz F, Hirankarn N, Jansen L, Wong VW, Soffredini R, Liang X, Chen S, Groothuismink ZMA, Santoro R, Jaroszewicz J, Ozaras R, Kozbial K, Brahmania M, Xie Q, Chotiyaputta W, Xun Q, Pazgan-Simon M, Oztas E, Verhey E, Montanari NR, Sun J, Hansen BE, Boonstra A, Janssen HLA; GIANT-B Global Consortium. Brouwer WP, et al. Among authors: tangkijvanich p. Clin Infect Dis. 2019 Nov 13;69(11):1969-1979. doi: 10.1093/cid/ciz084. Clin Infect Dis. 2019. PMID: 30715261 Free PMC article.

4

Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions.

Toyoda H, Hoshida Y, Parikh ND, Jalal PK, Piñero F, Mendizabal M, Ridruejo E, Cheinquer H, Casadei-Gardini A, Kanneganti M, Weinmann A, Peck-Radosavljevic M, Dufour JF, Radu P, Shiha G, Soliman R, Sarin SK, Kumar M, Wang JH, Tangkijvanich P, Sukeepaisarnjaroen W, Atsukawa M, Uojima H, Nozaki A, Nakamuta M, Takaguchi K, Hiraoka A, Abe H, Matsuura K, Watanabe T, Shimada N, Tsuji K, Ishikawa T, Mikami S, Itobayashi E, Johnson PJ, Singal AG. Toyoda H, et al. Among authors: tangkijvanich p. Liver Int. 2026 Jul;46(7):e70734. doi: 10.1111/liv.70734. Liver Int. 2026. PMID: 42257496 Free PMC article.

5

The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trial.

Yuen MF, Gane E, Holmes JA, Strasser SI, Leerapun A, Sukeepaisarnjaroen W, Tangkijvanich P, Berliba E, Jucov A, Kim YJ, Lim YS, Thi EP, Eley T, Gray KR, Medvedeva E, Sharma V, Espiritu C, Ganchua SC, Paratala BS, Iott C, Sevinsky H, Fortney T, Anderson M, Cloherty GA, Sofia MJ, Pamulapati GR, Lee ACH, Picchio G, Sims KD. Yuen MF, et al. Among authors: tangkijvanich p. Lancet Gastroenterol Hepatol. 2026 Jul;11(7):579-601. doi: 10.1016/S2468-1253(26)00058-0. Epub 2026 May 22. Lancet Gastroenterol Hepatol. 2026. PMID: 42173110 Clinical Trial.

6

Development of a longitudinal predictive model for hepatocellular carcinoma occurrence in patients with chronic hepatitis B.

Kaewdech A, Toh C, Sripongpun P, Chamroonkul N, Tangkijvanich P, Piratvisuth T, Liangpunsakul S, Thongsuksai P, Ingviya T. Kaewdech A, et al. Among authors: tangkijvanich p. Sci Rep. 2026 May 12. doi: 10.1038/s41598-026-47600-9. Online ahead of print. Sci Rep. 2026. PMID: 42120525 Free article.

7

Host Factors DDB2 and DNA Polymerase Delta Are Linked to cccDNA Persistence in Hepatitis B Virus and Occult Hepatitis B Virus-Related Hepatocellular Carcinoma.

Singsung K, Vorasittha A, Tangkijvanich P, Tanaka Y, Chuaypen N, Sirichindakul P. Singsung K, et al. Among authors: tangkijvanich p. J Viral Hepat. 2026 Jun;33(6):e70182. doi: 10.1111/jvh.70182. J Viral Hepat. 2026. PMID: 42083260

8

The association of clinical characteristics and liver stiffness measurement with liver viscosity measured by shear wave elastography in patient with non-alcoholic fatty liver disease.

Opasatian A, Tanpowpong N, Tangkijvanich P. Opasatian A, et al. Among authors: tangkijvanich p. Asian Biomed (Res Rev News). 2026 Apr 30;20(1):1-7. doi: 10.2478/abm-2026-0006. eCollection 2026 Feb. Asian Biomed (Res Rev News). 2026. PMID: 42077365 Free PMC article.

9

Intestinal Candida albicans is Associated with Subclinical Coronary Atherosclerosis in Metabolic Dysfunction-associated Steatotic Liver Disease with Cirrhosis.

Satthawiwat N, Visedthorn S, Ruengket P, Chanchaem P, Kongsomboonchoke P, Tumkosit M, Chattranukulchai P, Payungporn S, Tangkijvanich P. Satthawiwat N, et al. Among authors: tangkijvanich p. J Clin Transl Hepatol. 2026 Mar 28;14(3):269-279. doi: 10.14218/JCTH.2025.00507. Epub 2026 Jan 27. J Clin Transl Hepatol. 2026. PMID: 41970190 Free PMC article.

10

Gut Microbiome Signatures Differ in Cirrhosis With and Without Hepatocellular Carcinoma in a Southeast Asian Cohort.

Jinato T, Sikaroodia M, Gilleveta PM, Dissayabutra T, Tangkijvanich P, Bajaj JS, Chuaypen N. Jinato T, et al. Among authors: tangkijvanich p. J Gastroenterol Hepatol. 2026 May;41(5):1590-1599. doi: 10.1111/jgh.70358. Epub 2026 Mar 30. J Gastroenterol Hepatol. 2026. PMID: 41910033

11

Diabetes and risk of significant fibrosis in adults with HIV and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.

Han WM, Apornpong T, Chuaypen N, Aung TPP, Amornritvanich P, Hiranburana N, Lwin HMS, Hiransuthikul A, Kerr S, Tangkijvanich P, Avihingsanon A. Han WM, et al. Among authors: tangkijvanich p. J Antimicrob Chemother. 2026 Feb 2;81(3):dkag053. doi: 10.1093/jac/dkag053. J Antimicrob Chemother. 2026. PMID: 41710964 Free article.

12

Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia.

Takeuchi Y, Tateishi R, Obi S, Otsuka M, Mochizuki H, Jazag A, Yokosuka O, Ogasawara S, Kanogawa N, Gonchig E, Matsushita Y, Kekilli M, Bilican G, Kim YJ, Hur MH, Yu ML, Huang CF, Morishita A, Oura K, Komori A, Motoyoshi Y, Siregar L, Loho I, Yang M, Okabe S, Ueno Y, Katsumi T, Sato T, Kogure H, Masuzaki R, Lesmana CR, Nababan SHH, Nimanong S, Huang YH, Nagamatsu H, Yoshida H, Uchino K, Hasan I, Kitiyakara T, Akamatsu M, Okamoto M, Kondo M, Moriyama M, Sukeepaisarnjareon W, Tangkijvanich P, Thanapirom K, Yalcin K, Kızıl HD, Adali G, Akdogan M, Gokce DT, Balaban Y, Gokcan H, Coşar AM, Harputluoglu M, Bahçecioğlu İH, Atasoy A, Kockar MC, Dursun H, Eminler AT, Sollano J, Su DJ, Piratvisuth T, Kao JH, Crawford D, Hou J, Sharma BC, Payawal DA, Gani RA, Tanwandee T, Yang JM, Lin HC, Shiina S, Jia JD, Lau G, Örmeci N, Dokmeci AK, Wei L, Sarin SK, Omata M. Takeuchi Y, et al. Among authors: tangkijvanich p. Hepatol Int. 2026 Apr;20(2):373-383. doi: 10.1007/s12072-026-11037-z. Epub 2026 Feb 5. Hepatol Int. 2026. PMID: 41639358 Free PMC article.

13

Development of a Sensitive and Specific RPA-CRISPR/Cas12a Assay for Intrahepatic Quantification of HBV cccDNA.

Kongsomboonchoke P, Ariyachet C, Kaewsapsak P, Sirichindakul P, Tangkijvanich P. Kongsomboonchoke P, et al. Among authors: tangkijvanich p. Int J Mol Sci. 2026 Jan 5;27(1):551. doi: 10.3390/ijms27010551. Int J Mol Sci. 2026. PMID: 41516423 Free PMC article.

14

Economic evaluation of biomarker-based surveillance for Hepatocellular Carcinoma in Thai patients with Compensated Liver Cirrhosis.

Pinjaroen N, Pan-Ngum W, Poovorawan K, Wastlund D, Mueller F, Lu P, Yu RSS, Tangkijvanich P. Pinjaroen N, et al. Among authors: tangkijvanich p. PLoS One. 2026 Jan 5;21(1):e0337913. doi: 10.1371/journal.pone.0337913. eCollection 2026. PLoS One. 2026. PMID: 41490253 Free PMC article.

15

Gut microbiota and host transcriptome interactions reveal diagnostic biomarkers in MASLD-associated hepatocellular carcinoma.

Jinato T, Khamjerm J, Manprasong S, Iadsee N, Tangkijvanich P, Nookaew I, Chuaypen N. Jinato T, et al. Among authors: tangkijvanich p. Gut Pathog. 2025 Dec 16;17(1):107. doi: 10.1186/s13099-025-00782-5. Gut Pathog. 2025. PMID: 41402920 Free PMC article.

16

Functionalized laser-induced graphene enabled ultrasensitive electroimmunoassay for rapid hepatitis B virus detection.

Suea-Ngam A, Ngamyoo T, Chailapakul O, Rodthongkum N, Tangkijvanich P, Puthongkham P. Suea-Ngam A, et al. Among authors: tangkijvanich p. Bioelectrochemistry. 2026 Jun;169:109179. doi: 10.1016/j.bioelechem.2025.109179. Epub 2025 Nov 22. Bioelectrochemistry. 2026. PMID: 41297448

17

Electrochemical sensor for direct HIV-1 DNA detection using ruthenium assembled on a pyrrolidinyl peptide nucleic acid-DNA hybrid.

Chittuam K, Lersanansit N, Tangkijvanich P, Chuaypen N, Avihingsanon A, Vilaivan T, Sain M, Ngamrojanavanich N, Jampasa S, Chailapakul O. Chittuam K, et al. Among authors: tangkijvanich p. Bioelectrochemistry. 2026 Jun;169:109172. doi: 10.1016/j.bioelechem.2025.109172. Epub 2025 Nov 22. Bioelectrochemistry. 2026. PMID: 41289897

18

Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.

Wong GL, Yuen MF, Lin B, Douglas MW, Hu P, Xie Q, Lv F, Tak WY, Leerapun A, Kim DJ, Tangkijvanich P, Lim YS, Dai CY, O'Beirne J, Weltman M, Khemnark S, Piratvisuth T, Manasirisuk W, Chen X, Liu CJ, Heo J, Lee J, Niu J, Kumar R, Kumar R, Zhu C, Cao K, Tian A, Chen X, Zhu Q, Margolis D, Jia J, Hong Z. Wong GL, et al. Among authors: tangkijvanich p. Nat Med. 2026 Jan;32(1):151-159. doi: 10.1038/s41591-025-04049-z. Epub 2025 Nov 7. Nat Med. 2026. PMID: 41203919 Free PMC article. Clinical Trial.

19

Dietary composition modulate gut microbiota and related biomarkers in patients with chronic kidney disease.

Udomkarnjananun S, Chuaypen N, Metta K, Dissayabutra T, Sodsai P, Kittiskulnam P, Tangkijvanich P. Udomkarnjananun S, et al. Among authors: tangkijvanich p. Sci Rep. 2025 Oct 16;15(1):36274. doi: 10.1038/s41598-025-20266-5. Sci Rep. 2025. PMID: 41102296 Free PMC article.

20

Extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From intercellular signaling to clinical translation.

Boonkaew B, Charoenthanakitkul D, Suntornnont N, Ariyachet C, Tangkijvanich P. Boonkaew B, et al. Among authors: tangkijvanich p. World J Hepatol. 2025 Sep 27;17(9):108259. doi: 10.4254/wjh.v17.i9.108259. World J Hepatol. 2025. PMID: 41024874 Free PMC article. Review.

21

Magnetic resonance imaging radiomics for predicting hepatocellular carcinoma recurrence following resection or ablation: a systematic review and meta-analysis.

Maung ST, Tangkijvanich P, Chaiteerakij R. Maung ST, et al. Among authors: tangkijvanich p. Abdom Radiol (NY). 2026 Apr;51(4):1834-1853. doi: 10.1007/s00261-025-05184-4. Epub 2025 Sep 22. Abdom Radiol (NY). 2026. PMID: 40981987

22

Gut Dysbiosis and Plasma Trimethylamine Oxide Are Associated with Subclinical Coronary Atherosclerosis in Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.

Islam K, Kongsomboonchoke P, Chayanupatkul M, Tumkosit M, Chattranukulchai P, Prombutara P, Tangkijvanich P. Islam K, et al. Among authors: tangkijvanich p. Nutrients. 2025 Aug 26;17(17):2759. doi: 10.3390/nu17172759. Nutrients. 2025. PMID: 40944149 Free PMC article.

23

MicroRNA-372-3p impairs fatty acid metabolism in hepatocellular carcinoma cells by targeting CPT1A and ACSL4.

Phetkong C, Boonto T, Thamjamrassri P, Ariyachet C, Tangkijvanich P. Phetkong C, et al. Among authors: tangkijvanich p. Bioimpacts. 2025 Aug 20;15:31075. doi: 10.34172/bi.31075. eCollection 2025. Bioimpacts. 2025. PMID: 40922951 Free PMC article.

24

MicroRNA‑885‑5p regulates cell cycle progression in liver cancer cells.

Ariyachet C, Nokkeaw A, Tangkijvanich P. Ariyachet C, et al. Among authors: tangkijvanich p. Int J Mol Med. 2025 Nov;56(5):167. doi: 10.3892/ijmm.2025.5608. Epub 2025 Aug 14. Int J Mol Med. 2025. PMID: 40808344 Free PMC article.

25

The Distribution and Survival Association of Genetic Polymorphisms in Thai Patients with Hepatocellular Carcinoma According to Underlying Liver Disease.

Aung TCZ, Boonkaew B, Chayanupatkul M, Poovorawan K, Chuaypen N, Tangkijvanich P. Aung TCZ, et al. Among authors: tangkijvanich p. Genes (Basel). 2025 Jul 9;16(7):808. doi: 10.3390/genes16070808. Genes (Basel). 2025. PMID: 40725464 Free PMC article.

26

Roadmap for HCC Surveillance and Management in the Asia Pacific.

Kudo M, Oanh BT, Chen CJ, Ngat DT, George J, Kim DY, Pimsawadi L, Tangkijvanich P, Pwu RF, Mohamed R, Bunnag S, Lu SN, Kudtiyakarn S, Kanto T, Piratvisuth T, Wu CC, Sarno R; APAC Liver Disease Alliance. Kudo M, et al. Among authors: tangkijvanich p. Cancers (Basel). 2025 Jun 10;17(12):1928. doi: 10.3390/cancers17121928. Cancers (Basel). 2025. PMID: 40563580 Free PMC article.

27

The Cost-Effectiveness Analysis of Radiofrequency Ablation Compared to Hepatic Resection for Resectable Small Hepatocellular Carcinoma in Thailand.

Pinjaroen N, Kulpeng W, Tangkijvanich P, Kitiyakara T. Pinjaroen N, et al. Among authors: tangkijvanich p. Clin Ther. 2025 Aug;47(8):602-609. doi: 10.1016/j.clinthera.2025.05.014. Epub 2025 Jun 20. Clin Ther. 2025. PMID: 40544073

28

Palmitic acid reduces LDLR-dependent uptake of macrophage-derived extracellular vesicles by hepatoma cells.

Boonkaew B, Satthawiwat N, Pachane BC, Brett LM, Tangkijvanich P, Ariyachet C. Boonkaew B, et al. Among authors: tangkijvanich p. Noncoding RNA Res. 2025 Apr 28;13:71-83. doi: 10.1016/j.ncrna.2025.04.007. eCollection 2025 Aug. Noncoding RNA Res. 2025. PMID: 40476020 Free PMC article.

29

Characterization of gut dysbiosis and intestinal barrier dysfunction in patients with metabolic dysfunction-associated steatotic liver disease and chronic kidney disease: a comparative study.

Dissayabutra T, Chuaypen N, Somnark P, Boonkaew B, Udomkarnjananun S, Kittiskulnam P, Charoenchittang P, Prombutara P, Tangkijvanich P. Dissayabutra T, et al. Among authors: tangkijvanich p. Sci Rep. 2025 May 3;15(1):15481. doi: 10.1038/s41598-025-00237-6. Sci Rep. 2025. PMID: 40319096 Free PMC article.

30

Machine learning models for predicting hepatocellular carcinoma development in patients with chronic viral hepatitis B infection.

Kuaaroon W, Tiyarattanachai T, Apiparakoon T, Marukatat S, Tanpowpong N, Treeprasertsuk S, Rerknimitr R, Tangkijvanich P, Ananchuensook P, Chotiyaputta W, Samaithongcharoen K, Chaiteerakij R. Kuaaroon W, et al. Among authors: tangkijvanich p. Asian Biomed (Res Rev News). 2025 Feb 28;19(1):51-59. doi: 10.2478/abm-2025-0007. eCollection 2025 Feb. Asian Biomed (Res Rev News). 2025. PMID: 40231168 Free PMC article.

31

Diagnostic Performance of Serum Mac-2-Binding Protein Glycosylation Isomer as a Fibrosis Biomarker in Non-Obese and Obese Patients with MASLD.

Ananchuensook P, Moonlisarn K, Boonkaew B, Bunchorntavakul C, Tangkijvanich P. Ananchuensook P, et al. Among authors: tangkijvanich p. Biomedicines. 2025 Feb 9;13(2):415. doi: 10.3390/biomedicines13020415. Biomedicines. 2025. PMID: 40002828 Free PMC article.

32

Cost-Utility Analysis of Noninvasive Tests to Initiate Hepatocellular Carcinoma Surveillance in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Decharatanachart P, Poovorawan K, Tangkijvanich P, Charatcharoenwitthaya P, Peeraphatdit T, Taychakhoonavudh S, Treeprasertsuk S, Chaiteerakij R. Decharatanachart P, et al. Among authors: tangkijvanich p. Am J Gastroenterol. 2025 Nov 1;120(11):2592-2602. doi: 10.14309/ajg.0000000000003332. Epub 2025 Jan 29. Am J Gastroenterol. 2025. PMID: 39878449

33

Corrigendum to "Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B" [Antivi. Res. 231 (2024) 1-13/106017].

Tang Y, Xu M, Wang C, Wu M, Hu L, Li J, Lu W, Zheng Y, Zhang M, Jiang X, Zhu C, Audsley J, Tangkijvanich P, Avihingsanon A, Song S, Liu S, Lewin SR, George J, Douglas M, Ling Y, Yuan Z, Zhu L, Zhang Z, Zhang X. Tang Y, et al. Among authors: tangkijvanich p. Antiviral Res. 2025 Feb;234:106080. doi: 10.1016/j.antiviral.2025.106080. Epub 2025 Jan 14. Antiviral Res. 2025. PMID: 39809626 No abstract available.

34

Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis.

Thanapirom K, Suksawatamnuay S, Thaimai P, Ananchuensook P, Kijrattanakul P, Angchaisuksiri P, Tangkijvanich P, Treeprasertsuk S, Komolmit P. Thanapirom K, et al. Among authors: tangkijvanich p. Thromb Haemost. 2025 Nov;125(11):1141-1149. doi: 10.1055/a-2505-8616. Epub 2025 Jan 9. Thromb Haemost. 2025. PMID: 39788529 Free PMC article.

35

Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers.

Kim KS, Iwamoto M, Kitagawa K, Park H, Hayashi S, Tsukuda S, Matsui T, Atsukawa M, Matsuura K, Chuaypen N, Tangkijvanich P, Allweiss L, Nishiyama T, Nakamura N, Fujita Y, Kawakami E, Nakaoka S, Muramatsu M, Aihara K, Wakita T, Perelson AS, Dandri M, Watashi K, Iwami S, Tanaka Y. Kim KS, et al. Among authors: tangkijvanich p. PLoS Comput Biol. 2025 Jan 9;21(1):e1012615. doi: 10.1371/journal.pcbi.1012615. eCollection 2025 Jan. PLoS Comput Biol. 2025. PMID: 39787253 Free PMC article.

36

Interaction Between PNPLA3 and SIRT5 Genetic Variants in Association with Liver Fibrosis Severity in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.

Moonlisarn K, Somnark P, Boonkaew B, Bunchorntavakul C, Tangkijvanich P. Moonlisarn K, et al. Among authors: tangkijvanich p. Genes (Basel). 2024 Oct 24;15(11):1370. doi: 10.3390/genes15111370. Genes (Basel). 2024. PMID: 39596570 Free PMC article.

37

Performance of Elecsys^® HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection.

Ananchuensook P, Wongpiyabovorn J, Avihingsanon A, Tangkijvanich P. Ananchuensook P, et al. Among authors: tangkijvanich p. Diagnostics (Basel). 2024 Sep 29;14(19):2179. doi: 10.3390/diagnostics14192179. Diagnostics (Basel). 2024. PMID: 39410582 Free PMC article.

38

Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B.

Tang Y, Xu M, Wang C, Wu M, Hu L, Li J, Lu W, Zheng Y, Zhang M, Jiang X, Zhu C, Audsley J, Tangkijvanich P, Avihingsanon A, Song S, Liu S, Lewin SR, George J, Douglas MW, Ling Y, Yuan Z, Zhu L, Zhang Z, Zhang X. Tang Y, et al. Among authors: tangkijvanich p. Antiviral Res. 2024 Nov;231:106017. doi: 10.1016/j.antiviral.2024.106017. Epub 2024 Oct 11. Antiviral Res. 2024. PMID: 39396554

39

VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study.

Yuen MF, Lim YS, Yoon KT, Lim TH, Heo J, Tangkijvanich P, Tak WY, Thanawala V, Cloutier D, Mao S, Arizpe A, Cathcart AL, Gupta SV, Hwang C, Gane E. Yuen MF, et al. Among authors: tangkijvanich p. Lancet Gastroenterol Hepatol. 2024 Dec;9(12):1121-1132. doi: 10.1016/S2468-1253(24)00237-1. Epub 2024 Oct 8. Lancet Gastroenterol Hepatol. 2024. PMID: 39389081 Clinical Trial.

40

Exploring the Feasibility and Acceptability of a Telehealth Platform for Older Adults with Noncommunicable Diseases and Chronic Viral Hepatitis.

Chairuengjitjaras P, Nimmanterdwong Z, Petchlorlian A, Praditpornsilpa K, Tangkijvanich P. Chairuengjitjaras P, et al. Among authors: tangkijvanich p. Telemed J E Health. 2025 Mar;31(3):344-353. doi: 10.1089/tmj.2024.0289. Epub 2024 Oct 8. Telemed J E Health. 2025. PMID: 39379066

41

Association of PNPLA3 risk variant with steatotic liver disease among lean people with HIV mono-infection.

Han WM, Apornpong T, Chuaypen N, Tangkijvanich P, Avihingsanon A; HIV-NAT 006 team. Han WM, et al. Among authors: tangkijvanich p. J Hepatol. 2025 Jan;82(1):e32-e34. doi: 10.1016/j.jhep.2024.08.017. Epub 2024 Aug 31. J Hepatol. 2025. PMID: 39218226 No abstract available.

42

Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate-day treatment in hemodialysis patients with chronic hepatitis C infection.

Chariyavilaskul P, Prompila N, Wittayalertpanya S, Lekhyananda S, Prasithsirikul W, Trakarnvanich T, Jeenapongsa S, Susantitaphong P, Kerr S, Avihingsanon A, Tangkijvanich P, Praditpornsilpa K. Chariyavilaskul P, et al. Among authors: tangkijvanich p. Clin Transl Sci. 2024 Jul;17(7):e13884. doi: 10.1111/cts.13884. Clin Transl Sci. 2024. PMID: 39004798 Free PMC article.

43

Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD.

Satthawiwat N, Jinato T, Sutheeworapong S, Tanpowpong N, Chuaypen N, Tangkijvanich P. Satthawiwat N, et al. Among authors: tangkijvanich p. Nutrients. 2024 Jun 7;16(12):1800. doi: 10.3390/nu16121800. Nutrients. 2024. PMID: 38931155 Free PMC article.

44

Size-Dependent Electrochemistry of Laser-Induced Graphene Electrodes.

Wirojsaengthong S, Chailapakul O, Tangkijvanich P, Henry CS, Puthongkham P. Wirojsaengthong S, et al. Among authors: tangkijvanich p. Electrochim Acta. 2024 Aug 1;494:144452. doi: 10.1016/j.electacta.2024.144452. Epub 2024 May 16. Electrochim Acta. 2024. PMID: 38881690 Free PMC article.

45

Simplified Chronic Hepatitis B Antiviral Initiation Criteria in Thailand: An Economic Evaluation.

Dilokthornsakul P, Sawangjit R, Tangkijvanich P, Chayanupatkul M, Permsuwan U. Dilokthornsakul P, et al. Among authors: tangkijvanich p. Value Health Reg Issues. 2024 Sep;43:101011. doi: 10.1016/j.vhri.2024.101011. Epub 2024 Jun 7. Value Health Reg Issues. 2024. PMID: 38848612 Free article.

46

Classification of Long Non-Coding RNAs s Between Early and Late Stage of Liver Cancers From Non-coding RNA Profiles Using Machine-Learning Approach.

Anuntakarun S, Khamjerm J, Tangkijvanich P, Chuaypen N. Anuntakarun S, et al. Among authors: tangkijvanich p. Bioinform Biol Insights. 2024 Jun 5;18:11779322241258586. doi: 10.1177/11779322241258586. eCollection 2024. Bioinform Biol Insights. 2024. PMID: 38846329 Free PMC article.

47

ZNF469 is a profibrotic regulator of extracellular matrix in hepatic stellate cells.

Ariyachet C, Nokkeaw A, Boonkaew B, Tangkijvanich P. Ariyachet C, et al. Among authors: tangkijvanich p. J Cell Biochem. 2024 Jul;125(7):e30578. doi: 10.1002/jcb.30578. Epub 2024 May 5. J Cell Biochem. 2024. PMID: 38704698

48

Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand.

Sriphoosanaphan S, Pantumongkol W, Kulpeng W, Charonpongsuntorn C, Tanwandee T, Sukeepaisarnjaroen W, Sobhonslidsuk A, Tangkijvanich P. Sriphoosanaphan S, et al. Among authors: tangkijvanich p. PLoS One. 2024 Mar 21;19(3):e0300327. doi: 10.1371/journal.pone.0300327. eCollection 2024. PLoS One. 2024. PMID: 38512900 Free PMC article.

49

Gut Microbiota in Patients with Non-Alcoholic Fatty Liver Disease without Type 2 Diabetes: Stratified by Body Mass Index.

Chuaypen N, Asumpinawong A, Sawangsri P, Khamjerm J, Iadsee N, Jinato T, Sutheeworapong S, Udomsawaengsup S, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. Int J Mol Sci. 2024 Feb 2;25(3):1807. doi: 10.3390/ijms25031807. Int J Mol Sci. 2024. PMID: 38339096 Free PMC article.

50

Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma.

Jinato T, Anuntakarun S, Satthawiwat N, Chuaypen N, Tangkijvanich P. Jinato T, et al. Among authors: tangkijvanich p. Appl Microbiol Biotechnol. 2024 Dec;108(1):34. doi: 10.1007/s00253-023-12845-1. Epub 2024 Jan 6. Appl Microbiol Biotechnol. 2024. PMID: 38183473 Free PMC article.

51

H4K20me3 upregulated by reactive oxygen species is associated with tumor progression and poor prognosis in patients with hepatocellular carcinoma.

Phoyen S, Sanpavat A, Ma-On C, Stein U, Hirankarn N, Tangkijvanich P, Jindatip D, Whongsiri P, Boonla C. Phoyen S, et al. Among authors: tangkijvanich p. Heliyon. 2023 Nov 20;9(12):e22589. doi: 10.1016/j.heliyon.2023.e22589. eCollection 2023 Dec. Heliyon. 2023. PMID: 38144275 Free PMC article.

52

Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma.

Boonkaew B, Satthawiwat N, Pinjaroen N, Chuaypen N, Tangkijvanich P. Boonkaew B, et al. Among authors: tangkijvanich p. Int J Mol Sci. 2023 Nov 7;24(22):16043. doi: 10.3390/ijms242216043. Int J Mol Sci. 2023. PMID: 38003232 Free PMC article.

53

Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy.

Navadurong H, Prasoppokakorn T, Siriwong N, Phathong C, Teeyapun N, Tanasanvimon S, Thanapirom K, Komolmit P, Tangkijvanich P, Treeprasertsuk S, Chaiteerakij R. Navadurong H, et al. Among authors: tangkijvanich p. World J Gastrointest Oncol. 2023 Oct 15;15(10):1771-1783. doi: 10.4251/wjgo.v15.i10.1771. World J Gastrointest Oncol. 2023. PMID: 37969413 Free PMC article.

54

Binding characteristics of pyrrole-scaffold hepatitis B virus capsid inhibitors and identification of novel potent compounds.

Ruengsatra T, Meeprasert A, Rattanangkool E, Deesiri S, Srisa J, Udomnilobol U, Dunkoksung W, Chuaypen N, Kiatbumrung R, Tangkijvanich P, Vimolmangkang S, Pudhom K, Prueksaritanont T. Ruengsatra T, et al. Among authors: tangkijvanich p. RSC Adv. 2023 Oct 6;13(41):29004-29022. doi: 10.1039/d3ra04720b. eCollection 2023 Sep 26. RSC Adv. 2023. PMID: 37807973 Free PMC article.

55

Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis.

Nokkeaw A, Thamjamrassri P, Chantaravisoot N, Tangkijvanich P, Ariyachet C. Nokkeaw A, et al. Among authors: tangkijvanich p. Oncol Res. 2023 Sep 15;31(6):989-1005. doi: 10.32604/or.2023.030395. eCollection 2023. Oncol Res. 2023. PMID: 37744274 Free PMC article.

56

Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Pinjaroen N, Chailapakul P, Sriphoosanaphan S, Chuaypen N, Tangkijvanich P. Pinjaroen N, et al. Among authors: tangkijvanich p. Diagnostics (Basel). 2023 Aug 29;13(17):2794. doi: 10.3390/diagnostics13172794. Diagnostics (Basel). 2023. PMID: 37685331 Free PMC article.

57

Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection.

Chuaypen N, Jinato T, Avihingsanon A, Nookaew I, Tanaka Y, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. Sci Rep. 2023 Sep 2;13(1):14413. doi: 10.1038/s41598-023-41664-7. Sci Rep. 2023. PMID: 37660163 Free PMC article.

58

Cost-Utility Analysis of Non-Contrast Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance in Cirrhosis.

Decharatanachart P, Pan-Ngum W, Peeraphatdit T, Tanpowpong N, Tangkijvanich P, Treeprasertsuk S, Rerknimitr R, Chaiteerakij R. Decharatanachart P, et al. Among authors: tangkijvanich p. Gut Liver. 2024 Jan 15;18(1):135-146. doi: 10.5009/gnl230089. Epub 2023 Aug 10. Gut Liver. 2024. PMID: 37560799 Free PMC article.

59

First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection.

Gane EJ, Kim W, Lim TH, Tangkijvanich P, Yoon JH, Sievert W, Sukeepaisarnjaroen W, Thompson AJ, Pavlovic V, Surujbally B, Wat C, Brown BD, Achneck HE, Yuen MF. Gane EJ, et al. Among authors: tangkijvanich p. J Hepatol. 2023 Nov;79(5):1139-1149. doi: 10.1016/j.jhep.2023.07.026. Epub 2023 Jul 29. J Hepatol. 2023. PMID: 37524230 Clinical Trial.

60

Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis With Liver Fibrosis as Predictors of New-Onset Diabetes Mellitus in People With HIV: A Longitudinal Cohort Study.

Han WM, Apornpong T, Lwin HMS, Thammapiwan S, Boonrungsirisap J, Gatechompol S, Ubolyam S, Tangkijvanich P, Kerr SJ, Avihingsanon A. Han WM, et al. Among authors: tangkijvanich p. Clin Infect Dis. 2023 Dec 15;77(12):1687-1695. doi: 10.1093/cid/ciad433. Clin Infect Dis. 2023. PMID: 37477514 Free article.

61

Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand.

Janekrongtham C, Punsuwan N, Thitichai P, Lertpiriyasuwat C, Pan-Ngum W, Poovorawan K, Jantarapakde J, Tangkijvanich P. Janekrongtham C, et al. Among authors: tangkijvanich p. BMJ Open. 2023 Jul 19;13(7):e067275. doi: 10.1136/bmjopen-2022-067275. BMJ Open. 2023. PMID: 37474179 Free PMC article.

62

Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma.

Toyoda H, Kanneganti M, Melendez-Torres J, Parikh ND, Jalal PK, Piñero F, Mendizabal M, Ridruejo E, Cheinquer H, Casadei-Gardini A, Weinmann A, Peck-Radosavljevic M, Dufour JF, Radu P, Shiha G, Soliman R, Sarin SK, Kumar M, Wang JH, Tangkijvanich P, Sukeepaisarnjaroen W, Atsukawa M, Uojima H, Nozaki A, Nakamuta M, Takaguchi K, Hiraoka A, Abe H, Matsuura K, Watanabe T, Shimada N, Tsuji K, Ishikawa T, Mikami S, Itobayashi E, Singal AG, Johnson PJ. Toyoda H, et al. Among authors: tangkijvanich p. Clin Gastroenterol Hepatol. 2024 Jan;22(1):72-80.e4. doi: 10.1016/j.cgh.2023.06.026. Epub 2023 Jul 11. Clin Gastroenterol Hepatol. 2024. PMID: 37442316 Free article.

63

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.

Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group. Yuen MF, et al. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37442152 Clinical Trial.

64

Risk prediction algorithms in guiding antiviral therapy initiation among patients with chronic hepatitis B in Thailand: an economic evaluation and budget impact analysis.

Dilokthornsakul P, Sawangjit R, Tangkijvanich P, Chayanupatkul M, Sriuttha P, Permsuwan U. Dilokthornsakul P, et al. Among authors: tangkijvanich p. Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(8):951-958. doi: 10.1080/14737167.2023.2231636. Epub 2023 Jul 4. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 37381798

65

Electrochemical capillary-driven microfluidic DNA sensor for HIV-1 and HCV coinfection analysis.

Chittuam K, Jampasa S, Vilaivan T, Tangkijvanich P, Chuaypen N, Avihingsanon A, Sain M, Panraksa Y, Chailapakul O. Chittuam K, et al. Among authors: tangkijvanich p. Anal Chim Acta. 2023 Jul 18;1265:341257. doi: 10.1016/j.aca.2023.341257. Epub 2023 May 7. Anal Chim Acta. 2023. PMID: 37230584

66

Metabolic-Associated Fatty Liver Disease (MAFLD) is associated with immune activation, increased epicardial fat volume, and steatohepatitis among people with HIV in a Thai cohort.

Han WM, Apornpong T, Chattranukulchai P, Siwamogsatham S, Lwin HMS, Boonrungsirisap J, Wichiansan T, Gatechompol S, Ubolyam S, Kerr SJ, Tangkijvanich P, Avihingsanon A. Han WM, et al. Among authors: tangkijvanich p. HIV Med. 2023 Sep;24(9):1000-1012. doi: 10.1111/hiv.13499. Epub 2023 May 11. HIV Med. 2023. PMID: 37165782 Free article.

67

A Novel and Simplified Score for Determining Treatment Eligibility for Patients with Chronic Hepatitis B.

Geeratragool T, Tangkijvanich P, Nimanong S, Chainuvati S, Charatcharoenwitthaya P, Tanwandee T, Chotiyaputta W. Geeratragool T, et al. Among authors: tangkijvanich p. Viruses. 2023 Mar 10;15(3):724. doi: 10.3390/v15030724. Viruses. 2023. PMID: 36992433 Free PMC article.

68

An innovative wireless electrochemical card sensor for field-deployable diagnostics of Hepatitis B surface antigen.

Teengam P, Tangkijvanich P, Chuaypen N, Chailapakul O. Teengam P, et al. Among authors: tangkijvanich p. Sci Rep. 2023 Mar 2;13(1):3523. doi: 10.1038/s41598-023-30340-5. Sci Rep. 2023. PMID: 36864072 Free PMC article.

69

Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis.

Nokkeaw A, Thamjamrassri P, Tangkijvanich P, Ariyachet C. Nokkeaw A, et al. Among authors: tangkijvanich p. Cells. 2023 Jan 19;12(3):378. doi: 10.3390/cells12030378. Cells. 2023. PMID: 36766720 Free PMC article. Review.

70

Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection.

Thanapirom K, Suksawatamnuay S, Thaimai P, Treeprasertsuk S, Komolmit P, Tangkijvanich P. Thanapirom K, et al. Among authors: tangkijvanich p. Front Med (Lausanne). 2022 Oct 18;9:995857. doi: 10.3389/fmed.2022.995857. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36330056 Free PMC article.

71

meta-Ureidophenoxy-1,2,3-triazole hybrid as a novel scaffold for promising HepG2 hepatocellular carcinoma inhibitors: Synthesis, biological evaluation and molecular docking studies.

Limpachayaporn P, Nuchpun S, Sirirak J, Charoensuksai P, Wongprayoon P, Chuaypen N, Tangkijvanich P, Suksamrarn A. Limpachayaporn P, et al. Among authors: tangkijvanich p. Bioorg Med Chem. 2022 Nov 15;74:117048. doi: 10.1016/j.bmc.2022.117048. Epub 2022 Oct 7. Bioorg Med Chem. 2022. PMID: 36270111

72

Prevalence, Risk Factors, and Prognosis of Liver Involvement in Adult Patients with Chikungunya in Thailand.

Srikirin P, Siripoon T, Charoenpong L, Soonthornworasiri N, Matsee W, Kittitrakul C, Tangkijvanich P, Charunwatthana P, Poovorawan K. Srikirin P, et al. Among authors: tangkijvanich p. Am J Trop Med Hyg. 2022 Oct 17;107(5):1107-1113. doi: 10.4269/ajtmh.22-0339. Print 2022 Nov 14. Am J Trop Med Hyg. 2022. PMID: 36252802 Free PMC article.

73

Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B.

Yuen MF, Berliba E, Sukeepaisarnjaroen W, Ahn SH, Tanwandee T, Lim YS, Kim YJ, Poovorawan K, Tangkijvanich P, Schwabe C, Eley T, Brown J, Lee ACH, Thi EP, Paratala B, Mani N, Sofia MJ, Picchio G, Sims KD, Gane EJ. Yuen MF, et al. Among authors: tangkijvanich p. Hepatol Commun. 2022 Dec;6(12):3457-3472. doi: 10.1002/hep4.2095. Epub 2022 Oct 4. Hepatol Commun. 2022. PMID: 36194181 Free PMC article. Clinical Trial.

74

Physician- and patient-reported barriers to hepatocellular carcinoma surveillance: A nationwide survey.

Teerasarntipan T, Sritunyarat Y, Prathyajuta P, Pitakkitnukun P, Phathong C, Ariyaskul D, Kulkraisri K, Tangkijvanich P, Treeprasertsuk S, Rerknimitr R, Chaiteerakij R. Teerasarntipan T, et al. Among authors: tangkijvanich p. Medicine (Baltimore). 2022 Sep 9;101(36):e30538. doi: 10.1097/MD.0000000000030538. Medicine (Baltimore). 2022. PMID: 36086710 Free PMC article.

75

The Efficacy of Oligonol in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blinded Placebo-Controlled Trial.

Chayanupatkul M, Sawatdee W, Chutaputti A, Tangkijvanich P. Chayanupatkul M, et al. Among authors: tangkijvanich p. J Integr Complement Med. 2022 Nov;28(11):904-908. doi: 10.1089/jicm.2021.0362. Epub 2022 Sep 7. J Integr Complement Med. 2022. PMID: 36074799 Clinical Trial.

76

MicroRNA-223 Suppresses Human Hepatic Stellate Cell Activation Partly via Regulating the Actin Cytoskeleton and Alleviates Fibrosis in Organoid Models of Liver Injury.

Ariyachet C, Chuaypen N, Kaewsapsak P, Chantaravisoot N, Jindatip D, Potikanond S, Tangkijvanich P. Ariyachet C, et al. Among authors: tangkijvanich p. Int J Mol Sci. 2022 Aug 19;23(16):9380. doi: 10.3390/ijms23169380. Int J Mol Sci. 2022. PMID: 36012644 Free PMC article.

77

Electrochemical immunoassay for detection of hepatitis C virus core antigen using electrode modified with Pt-decorated single-walled carbon nanotubes.

Pusomjit P, Teengam P, Chuaypen N, Tangkijvanich P, Thepsuparungsikul N, Chailapakul O. Pusomjit P, et al. Among authors: tangkijvanich p. Mikrochim Acta. 2022 Aug 19;189(9):339. doi: 10.1007/s00604-022-05400-8. Mikrochim Acta. 2022. PMID: 35982360

78

Litchi-Derived Polyphenol Alleviates Liver Steatosis and Gut Dysbiosis in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blinded, Placebo-Controlled Study.

Jinato T, Chayanupatkul M, Dissayabutra T, Chutaputti A, Tangkijvanich P, Chuaypen N. Jinato T, et al. Among authors: tangkijvanich p. Nutrients. 2022 Jul 16;14(14):2921. doi: 10.3390/nu14142921. Nutrients. 2022. PMID: 35889878 Free PMC article. Clinical Trial.

79

Transcriptomic Analyses Reveal Long Non-Coding RNA in Peripheral Blood Mononuclear Cells as a Novel Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma.

Kunadirek P, Pinjaroen N, Nookaew I, Tangkijvanich P, Chuaypen N. Kunadirek P, et al. Among authors: tangkijvanich p. Int J Mol Sci. 2022 Jul 17;23(14):7882. doi: 10.3390/ijms23147882. Int J Mol Sci. 2022. PMID: 35887228 Free PMC article.

80

Genome-Wide Association Study for Chronic Hepatitis B Infection in the Thai Population.

Ashouri S, Khor SS, Hitomi Y, Sawai H, Nishida N, Sugiyama M, Kawai Y, Posuwan N, Tangkijvanich P, Komolmit P, Tsuiji M, Shotelersuk V, Poovorawan Y, Mizokami M, Tokunaga K. Ashouri S, et al. Among authors: tangkijvanich p. Front Genet. 2022 Jun 13;13:887121. doi: 10.3389/fgene.2022.887121. eCollection 2022. Front Genet. 2022. PMID: 35769989 Free PMC article.

81

Targeted Proteins Reveal Cathepsin D as a Novel Biomarker in Differentiating Hepatocellular Carcinoma from Cirrhosis and Other Liver Cancers.

Chuaypen N, Sriphoosanaphan S, Vorasittha A, Pinjaroen N, Chaiyarit S, Thongboonkerd V, Tangkijvanich P, Sirichindakul P. Chuaypen N, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2022 Jun 1;23(6):2017-2025. doi: 10.31557/APJCP.2022.23.6.2017. Asian Pac J Cancer Prev. 2022. PMID: 35763644 Free PMC article.

82

Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants.

Chuaypen N, Siripongsakun S, Hiranrat P, Tanpowpong N, Avihingsanon A, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. PLoS One. 2022 Jun 13;17(6):e0269641. doi: 10.1371/journal.pone.0269641. eCollection 2022. PLoS One. 2022. PMID: 35696400 Free PMC article.

83

The Design and Synthesis of a New Series of 1,2,3-Triazole-Cored Structures Tethering Aryl Urea and Their Highly Selective Cytotoxicity toward HepG2.

Oekchuae S, Sirirak J, Charoensuksai P, Wongprayoon P, Chuaypen N, Boonsombat J, Ruchirawat S, Tangkijvanich P, Suksamrarn A, Limpachayaporn P. Oekchuae S, et al. Among authors: tangkijvanich p. Pharmaceuticals (Basel). 2022 Apr 20;15(5):504. doi: 10.3390/ph15050504. Pharmaceuticals (Basel). 2022. PMID: 35631331 Free PMC article.

84

Clinical Utility of SCALE-B to Predict Hepatitis B Virus Relapse, Hepatitis B Surface Antigen Loss After Antiviral Cessation in Asian Patients After 2-Year Follow-up.

Kaewdech A, Assawasuwannakit S, Sripongpun P, Chamroonkul N, Tangkijvanich P, Piratvisuth T. Kaewdech A, et al. Among authors: tangkijvanich p. Front Med (Lausanne). 2022 Mar 24;9:859430. doi: 10.3389/fmed.2022.859430. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35402452 Free PMC article.

85

High Proportion of Blood-Borne and Sexually Transmitted Infections Among People Deprived of Liberty in a Central Male Prison in Thailand: A Cross-Sectional Study 2018-2019.

Harnpariphan W, Han WM, Supanun R, Ubolyam S, Sophonphan J, Ueaphongsukkit T, Gatechompol S, Tangkijvanich P, Thanprasertsuk S, Khwairakpam G, Ruxrungthan K, Phanuphak P, Matthews GV, Avihingsanon A. Harnpariphan W, et al. Among authors: tangkijvanich p. AIDS Res Hum Retroviruses. 2022 May;38(5):370-377. doi: 10.1089/AID.2021.0134. Epub 2022 Mar 31. AIDS Res Hum Retroviruses. 2022. PMID: 35262414

86

Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand.

Dilokthornsakul P, Sawangjit R, Tangkijvanich P, Chayanupatkul M, Tanwandee T, Sukeepaisarnjaroen W, Sriuttha P, Permsuwan U. Dilokthornsakul P, et al. Among authors: tangkijvanich p. Appl Health Econ Health Policy. 2022 Jul;20(4):587-596. doi: 10.1007/s40258-022-00719-y. Epub 2022 Feb 10. Appl Health Econ Health Policy. 2022. PMID: 35141850

87

Droplet digital PCR assay provides intrahepatic HBV cccDNA quantification tool for clinical application.

Hayashi S, Isogawa M, Kawashima K, Ito K, Chuaypen N, Morine Y, Shimada M, Higashi-Kuwata N, Watanabe T, Tangkijvanich P, Mitsuya H, Tanaka Y. Hayashi S, et al. Among authors: tangkijvanich p. Sci Rep. 2022 Feb 8;12(1):2133. doi: 10.1038/s41598-022-05882-9. Sci Rep. 2022. PMID: 35136096 Free PMC article.

88

Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia.

Chuaypen N, Khlaiphuengsin A, Prasoppokakorn T, Susantitaphong P, Prasithsirikul W, Avihingsanon A, Tangkijvanich P, Praditpornsilpa K. Chuaypen N, et al. Among authors: tangkijvanich p. BMC Infect Dis. 2022 Jan 22;22(1):79. doi: 10.1186/s12879-022-07074-2. BMC Infect Dis. 2022. PMID: 35065604 Free PMC article.

89

Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection.

Gane EJ, Schwabe C, Berliba E, Tangkijvanich P, Jucov A, Ghicavii N, Verbinnen T, Lenz O, Talloen W, Kakuda TN, Westland C, Patel M, Yogaratnam JZ, Dragone L, Van Remoortere P. Gane EJ, et al. Among authors: tangkijvanich p. J Antimicrob Chemother. 2022 Mar 31;77(4):1102-1110. doi: 10.1093/jac/dkab491. J Antimicrob Chemother. 2022. PMID: 35040959 Free PMC article. Clinical Trial.

90

Human-Centered Design of Mobile Health Apps for Older Adults: Systematic Review and Narrative Synthesis.

Nimmanterdwong Z, Boonviriya S, Tangkijvanich P. Nimmanterdwong Z, et al. Among authors: tangkijvanich p. JMIR Mhealth Uhealth. 2022 Jan 14;10(1):e29512. doi: 10.2196/29512. JMIR Mhealth Uhealth. 2022. PMID: 35029535 Free PMC article.

91

Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers-Led Model for HCV Microelimination in Thailand.

Supanan R, Han WM, Harnpariphan W, Ueaphongsukkit T, Ubolyam S, Sophonphan J, Tangkijvanich P, Thanprasertsuk S, Avihingsanon A; HIV-NAT HCV Study Team. Supanan R, et al. Among authors: tangkijvanich p. J Acquir Immune Defic Syndr. 2021 Dec 15;88(5):465-469. doi: 10.1097/QAI.0000000000002801. J Acquir Immune Defic Syndr. 2021. PMID: 34757974

92

Use of Hepatitis B-e Antigen to Identify Pregnant Women With Hepatitis B Virus Infection Who Need Antiviral Therapy for Prevention of Mother-to-child Transmission.

Jiragraivutidej C, Tangkijvanich P, Chaithongwongwatthana S. Jiragraivutidej C, et al. Among authors: tangkijvanich p. Cureus. 2021 Oct 1;13(10):e18430. doi: 10.7759/cureus.18430. eCollection 2021 Oct. Cureus. 2021. PMID: 34737899 Free PMC article.

93

An alternative label-free DNA sensor based on the alternating-current electroluminescent device for simultaneous detection of human immunodeficiency virus and hepatitis C co-infection.

Srisomwat C, Yakoh A, Avihingsanon A, Chuaypen N, Tangkijvanich P, Vilaivan T, Chailapakul O. Srisomwat C, et al. Among authors: tangkijvanich p. Biosens Bioelectron. 2022 Jan 15;196:113719. doi: 10.1016/j.bios.2021.113719. Epub 2021 Oct 15. Biosens Bioelectron. 2022. PMID: 34706315

94

Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study.

Ma H, Lim TH, Leerapun A, Weltman M, Jia J, Lim YS, Tangkijvanich P, Sukeepaisarnjaroen W, Ji Y, Le Bert N, Li D, Zhang Y, Hamatake R, Tan N, Li C, Strasser SI, Ding H, Yoon JH, Stace NH, Ahmed T, Anderson DE, Yan L, Bertoletti A, Zhu Q, Yuen MF. Ma H, et al. Among authors: tangkijvanich p. JHEP Rep. 2021 Sep 8;3(6):100361. doi: 10.1016/j.jhepr.2021.100361. eCollection 2021 Dec. JHEP Rep. 2021. PMID: 34661089 Free PMC article.

95

Identification and validation of circulating miRNAs as potential new biomarkers for severe liver disease in patients with leptospirosis.

Chuaypen N, Limothai U, Kunadirek P, Kaewsapsak P, Kueanjinda P, Srisawat N, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. PLoS One. 2021 Sep 27;16(9):e0257805. doi: 10.1371/journal.pone.0257805. eCollection 2021. PLoS One. 2021. PMID: 34570814 Free PMC article.

96

The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma.

Puthdee N, Sriswasdi S, Pisitkun T, Ratanasirintrawoot S, Israsena N, Tangkijvanich P. Puthdee N, et al. Among authors: tangkijvanich p. Cancer Gene Ther. 2022 May;29(5):445-455. doi: 10.1038/s41417-021-00387-5. Epub 2021 Sep 21. Cancer Gene Ther. 2022. PMID: 34548635 Free PMC article.

97

Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study.

Erken R, Andre P, Roy E, Kootstra N, Barzic N, Girma H, Laveille C, Radreau-Pierini P, Darteil R, Vonderscher J, Scalfaro P, Tangkijvanich P, Flisiak R, Reesink H. Erken R, et al. Among authors: tangkijvanich p. J Viral Hepat. 2021 Dec;28(12):1690-1698. doi: 10.1111/jvh.13608. Epub 2021 Sep 29. J Viral Hepat. 2021. PMID: 34467593 Free PMC article. Clinical Trial.

98

An automated fast-flow/delayed paper-based platform for the simultaneous electrochemical detection of hepatitis B virus and hepatitis C virus core antigen.

Boonkaew S, Yakoh A, Chuaypen N, Tangkijvanich P, Rengpipat S, Siangproh W, Chailapakul O. Boonkaew S, et al. Among authors: tangkijvanich p. Biosens Bioelectron. 2021 Dec 1;193:113543. doi: 10.1016/j.bios.2021.113543. Epub 2021 Aug 5. Biosens Bioelectron. 2021. PMID: 34416431

99

The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma.

Patarat R, Riku S, Kunadirek P, Chuaypen N, Tangkijvanich P, Mutirangura A, Puttipanyalears C. Patarat R, et al. Among authors: tangkijvanich p. Sci Rep. 2021 Jul 21;11(1):14838. doi: 10.1038/s41598-021-94330-1. Sci Rep. 2021. PMID: 34290294 Free PMC article.

100

Fluorescent paper-based DNA sensor using pyrrolidinyl peptide nucleic acids for hepatitis C virus detection.

Teengam P, Nisab N, Chuaypen N, Tangkijvanich P, Vilaivan T, Chailapakul O. Teengam P, et al. Among authors: tangkijvanich p. Biosens Bioelectron. 2021 Oct 1;189:113381. doi: 10.1016/j.bios.2021.113381. Epub 2021 May 29. Biosens Bioelectron. 2021. PMID: 34090155

101

Cell-Free DNA Analysis by Whole-Exome Sequencing for Hepatocellular Carcinoma: A Pilot Study in Thailand.

Kunadirek P, Chuaypen N, Jenjaroenpun P, Wongsurawat T, Pinjaroen N, Sirichindakul P, Nookaew I, Tangkijvanich P. Kunadirek P, et al. Among authors: tangkijvanich p. Cancers (Basel). 2021 May 6;13(9):2229. doi: 10.3390/cancers13092229. Cancers (Basel). 2021. PMID: 34066484 Free PMC article.

102

Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.

Kunadirek P, Ariyachet C, Sriphoosanaphan S, Pinjaroen N, Sirichindakul P, Nookaew I, Chuaypen N, Tangkijvanich P. Kunadirek P, et al. Among authors: tangkijvanich p. Sci Rep. 2021 May 27;11(1):11201. doi: 10.1038/s41598-021-90515-w. Sci Rep. 2021. PMID: 34045534 Free PMC article.

103

Identification of microRNA-96-5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma.

Matsui T, Hamada-Tsutsumi S, Naito Y, Nojima M, Iio E, Tamori A, Kubo S, Ide T, Kondo Y, Eguchi Y, Komori A, Morine Y, Shimada M, Utsunomiya T, Shirabe K, Kimura K, Hiasa Y, Chuaypen N, Tangkijvanich P, Naiki-Ito A, Takahashi S, Ochiya T, Tanaka Y. Matsui T, et al. Among authors: tangkijvanich p. Hepatol Res. 2022 Jan;52(1):93-104. doi: 10.1111/hepr.13674. Epub 2021 Jun 14. Hepatol Res. 2022. PMID: 34038612

104

Synthesis of sorafenib analogues incorporating a 1,2,3-triazole ring and cytotoxicity towards hepatocellular carcinoma cell lines.

Palakhachane S, Ketkaew Y, Chuaypen N, Sirirak J, Boonsombat J, Ruchirawat S, Tangkijvanich P, Suksamrarn A, Limpachayaporn P. Palakhachane S, et al. Among authors: tangkijvanich p. Bioorg Chem. 2021 Jul;112:104831. doi: 10.1016/j.bioorg.2021.104831. Epub 2021 Mar 17. Bioorg Chem. 2021. PMID: 33831675

105

Novel viral markers and the prediction of off-treatment relapse in chronic hepatitis B patients: A systematic review.

Jaroenlapnopparat A, Chayanupatkul M, Tangkijvanich P. Jaroenlapnopparat A, et al. Among authors: tangkijvanich p. J Gastroenterol Hepatol. 2021 Sep;36(9):2349-2362. doi: 10.1111/jgh.15516. Epub 2021 Apr 13. J Gastroenterol Hepatol. 2021. PMID: 33811375

106

Liver fibrosis improvement assessed by magnetic resonance elastography and Mac-2-binding protein glycosylation isomer in patients with hepatitis C virus infection receiving direct-acting antivirals.

Chuaypen N, Chittmittrapap S, Avihingsanon A, Siripongsakun S, Wongpiyabovorn J, Tanpowpong N, Tanaka Y, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. Hepatol Res. 2021 May;51(5):528-537. doi: 10.1111/hepr.13630. Epub 2021 Mar 16. Hepatol Res. 2021. PMID: 33615687

107

Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients With or Without Human Immunodeficiency Virus Coinfection.

Chuaypen N, Jinato T, Avihingsanon A, Chirapongsathorn S, Cheevadhanarak S, Nookaew I, Tanaka Y, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. J Infect Dis. 2021 Oct 28;224(8):1410-1421. doi: 10.1093/infdis/jiab094. J Infect Dis. 2021. PMID: 33598686 Free PMC article.

108

Successful direct-acting antiviral therapy improves circulating mucosal-associated invariant T cells in patients with chronic HCV infection.

Khlaiphuengsin A, Chuaypen N, Sodsai P, Reantragoon R, Han WM, Avihingsanon A, Tangkijvanich P. Khlaiphuengsin A, et al. Among authors: tangkijvanich p. PLoS One. 2020 Dec 31;15(12):e0244112. doi: 10.1371/journal.pone.0244112. eCollection 2020. PLoS One. 2020. PMID: 33382729 Free PMC article. Clinical Trial.

109

Amplification-free DNA Sensor for the One-Step Detection of the Hepatitis B Virus Using an Automated Paper-Based Lateral Flow Electrochemical Device.

Srisomwat C, Yakoh A, Chuaypen N, Tangkijvanich P, Vilaivan T, Chailapakul O. Srisomwat C, et al. Among authors: tangkijvanich p. Anal Chem. 2021 Feb 9;93(5):2879-2887. doi: 10.1021/acs.analchem.0c04283. Epub 2020 Dec 16. Anal Chem. 2021. PMID: 33326737

110

Incident Liver Cirrhosis, Associated Factors, and Cardiovascular Disease Risks Among People Living With HIV: A Longitudinal Study.

Han WM, Ueaphongsukkit T, Chattranukulchai P, Siwamogsatham S, Chaiteerakij R, Sophonphan J, Gatechompol S, Ubolyam S, Phonphithak S, Ruxrungtham K, Tangkijvanich P, Avihingsanon Y, Kerr SJ, Avihingsanon A. Han WM, et al. Among authors: tangkijvanich p. J Acquir Immune Defic Syndr. 2021 Apr 1;86(4):463-472. doi: 10.1097/QAI.0000000000002585. J Acquir Immune Defic Syndr. 2021. PMID: 33273213

111

Circulating microtranscriptome profiles reveal distinct expression of microRNAs in severe leptospirosis.

Limothai U, Dinhuzen J, Payongsri T, Tachaboon S, Tangkijvanich P, Chuaypen N, Srisawat N. Limothai U, et al. Among authors: tangkijvanich p. PLoS Negl Trop Dis. 2020 Nov 11;14(11):e0008809. doi: 10.1371/journal.pntd.0008809. eCollection 2020 Nov. PLoS Negl Trop Dis. 2020. PMID: 33175842 Free PMC article.

112

Acute liver failure and death predictors in patients with dengue-induced severe hepatitis.

Teerasarntipan T, Chaiteerakij R, Komolmit P, Tangkijvanich P, Treeprasertsuk S. Teerasarntipan T, et al. Among authors: tangkijvanich p. World J Gastroenterol. 2020 Sep 7;26(33):4983-4995. doi: 10.3748/wjg.v26.i33.4983. World J Gastroenterol. 2020. PMID: 32952344 Free PMC article.

113

Efficacy of elbasvir/grazoprevir therapy in HCV genotype-1 with or without HIV infection: role of HCV core antigen monitoring and improvement of liver stiffness and steatosis.

Chayanupatkul M, Chittmittraprap S, Pratedrat P, Chuaypen N, Avihingsanon A, Tangkijvanich P. Chayanupatkul M, et al. Among authors: tangkijvanich p. Antivir Ther. 2020;25(6):305-314. doi: 10.3851/IMP3370. Antivir Ther. 2020. PMID: 32910788

114

Hepatitis B surface antigen, core-related antigen and HBV RNA: Predicting clinical relapse after NA therapy discontinuation.

Kaewdech A, Tangkijvanich P, Sripongpun P, Witeerungrot T, Jandee S, Tanaka Y, Piratvisuth T. Kaewdech A, et al. Among authors: tangkijvanich p. Liver Int. 2020 Dec;40(12):2961-2971. doi: 10.1111/liv.14606. Epub 2020 Aug 3. Liver Int. 2020. PMID: 32668074

115

Large transmission cluster of acute hepatitis C identified among HIV-positive men who have sex with men in Bangkok, Thailand.

Han WM, Colby DJ, Khlaiphuengsin A, Apornpong T, Kerr SJ, Ubolyam S, Kroon E, Phanuphak N, Vasan S, Matthews GV, Avihingsanon A, Ruxrungtham K, Phanuphak P, Tangkijvanich P. Han WM, et al. Among authors: tangkijvanich p. Liver Int. 2020 Sep;40(9):2104-2109. doi: 10.1111/liv.14578. Epub 2020 Jul 20. Liver Int. 2020. PMID: 32574394

116

Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma.

Khlaiphuengsin A, Chuaypen N, Sodsai P, Buranapraditkun S, Boonpiyathad T, Hirankarn N, Tangkijvanich P. Khlaiphuengsin A, et al. Among authors: tangkijvanich p. World J Gastroenterol. 2020 May 28;26(20):2645-2656. doi: 10.3748/wjg.v26.i20.2645. World J Gastroenterol. 2020. PMID: 32523317 Free PMC article.

117

Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants.

Yoshida K, Desbiolles A, Feldman SF, Ahn SH, Alidjinou EK, Atsukawa M, Bocket L, Brunetto MR, Buti M, Carey I, Caviglia GP, Chen EQ, Cornberg M, Enomoto M, Honda M, Zu Siederdissen CH, Ishigami M, Janssen HLA, Maasoumy B, Matsui T, Matsumoto A, Nishiguchi S, Riveiro-Barciela M, Takaki A, Tangkijvanich P, Toyoda H, van Campenhout MJH, Wang B, Wei L, Yang HI, Yano Y, Yatsuhashi H, Yuen MF, Tanaka E, Lemoine M, Tanaka Y, Shimakawa Y. Yoshida K, et al. Among authors: tangkijvanich p. Clin Gastroenterol Hepatol. 2021 Jan;19(1):46-60.e8. doi: 10.1016/j.cgh.2020.04.045. Epub 2020 Apr 29. Clin Gastroenterol Hepatol. 2021. PMID: 32360825 Free article.

118

Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.

Pratedrat P, Chuaypen N, Nimsamer P, Payungporn S, Pinjaroen N, Sirichindakul B, Tangkijvanich P. Pratedrat P, et al. Among authors: tangkijvanich p. PLoS One. 2020 Apr 24;15(4):e0232211. doi: 10.1371/journal.pone.0232211. eCollection 2020. PLoS One. 2020. PMID: 32330203 Free PMC article.

119

Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography.

Teeratorn N, Piyachaturawat P, Thanapirom K, Chaiteerakij R, Sonsiri K, Komolmit P, Tangkijvanich P, Rerknimitr R, Adams L, Treeprasertsuk S. Teeratorn N, et al. Among authors: tangkijvanich p. JGH Open. 2019 Sep 4;4(2):245-250. doi: 10.1002/jgh3.12252. eCollection 2020 Apr. JGH Open. 2019. PMID: 32280772 Free PMC article.

120

Reverse transcriptase droplet digital PCR vs reverse transcriptase quantitative real-time PCR for serum HBV RNA quantification.

Limothai U, Chuaypen N, Poovorawan K, Chotiyaputta W, Tanwandee T, Poovorawan Y, Tangkijvanich P. Limothai U, et al. Among authors: tangkijvanich p. J Med Virol. 2020 Dec;92(12):3365-3372. doi: 10.1002/jmv.25792. Epub 2020 Apr 1. J Med Virol. 2020. PMID: 32219874

121

Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study.

Charatcharoenwitthaya P, Wongpaitoon V, Komolmit P, Sukeepaisarnjaroen W, Tangkijvanich P, Piratvisuth T, Sanpajit T, Sutthivana C, Bunchorntavakul C, Sobhonslidsuk A, Chonprasertsuk S, Siripipattanamongkol C, Sethasine S, Tanwandee T; THASL Collaborating Group for the Study of the Use of Direct-acting Antivirals for Chronic Hepatitis C. Charatcharoenwitthaya P, et al. Among authors: tangkijvanich p. BMC Gastroenterol. 2020 Mar 5;20(1):47. doi: 10.1186/s12876-020-01196-0. BMC Gastroenterol. 2020. PMID: 32138687 Free PMC article.

122

Awareness, knowledge, and practice for hepatitis B infection in Southeast Asia: a cross-sectional study.

Soe KP, Pan-Ngum W, Nontprasert A, Kittitrakul C, Oam N, Thong VD, Tangkijvanich P, Leowattana W, Poovorawan K. Soe KP, et al. Among authors: tangkijvanich p. J Infect Dev Ctries. 2019 Jul 31;13(7):656-664. doi: 10.3855/jidc.10479. J Infect Dev Ctries. 2019. PMID: 32065824 Free article.

123

Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients.

Sripongpun P, Tangkijvanich P, Chotiyaputta W, Charatcharoenwitthaya P, Chaiteerakij R, Treeprasertsuk S, Bunchorntavakul C, Sobhonslidsuk A, Leerapun A, Khemnark S, Poovorawan K, Siramolpiwat S, Chirapongsathorn S, Pan-Ngum W, Soonthornworasiri N, Sukeepaisarnjaroen W; THASL study group. Sripongpun P, et al. Among authors: tangkijvanich p. JGH Open. 2019 Jun 26;4(1):69-74. doi: 10.1002/jgh3.12219. eCollection 2020 Feb. JGH Open. 2019. PMID: 32055700 Free PMC article.

124

Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Regulates Host Gene PPM1A Related to Hepatocellular Carcinoma.

Chavalit T, Nimsamer P, Sirivassanametha K, Anuntakarun S, Saengchoowong S, Tangkijvanich P, Payungporn S. Chavalit T, et al. Among authors: tangkijvanich p. Microrna. 2020;9(3):232-239. doi: 10.2174/2211536608666191104105334. Microrna. 2020. PMID: 31686644

125

Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C.

Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Thaimai P, Wasitthankasem R, Poovorawan Y, Komolmit P. Thanapirom K, et al. Among authors: tangkijvanich p. PeerJ. 2019 Sep 11;7:e7666. doi: 10.7717/peerj.7666. eCollection 2019. PeerJ. 2019. PMID: 31565578 Free PMC article.

126

Association between Hepatitis B Surface Antigen Levels and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection: Systematic Review and Meta-Analysis.

Thi Vo T, Poovorawan K, Charoen P, Soonthornworasiri N, Nontprasert A, Kittitrakul C, Phumratanaprapin W, Tangkijvanich P. Thi Vo T, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2239-2246. doi: 10.31557/APJCP.2019.20.8.2239. Asian Pac J Cancer Prev. 2019. PMID: 31450890 Free PMC article.

127

Baseline and kinetics of serum hepatitis B virus RNA predict response to pegylated interferon-based therapy in patients with hepatitis B e antigen-negative chronic hepatitis B.

Limothai U, Chuaypen N, Poovorawan K, Chotiyaputta W, Tanwandee T, Poovorawan Y, Tangkijvanich P. Limothai U, et al. Among authors: tangkijvanich p. J Viral Hepat. 2019 Dec;26(12):1481-1488. doi: 10.1111/jvh.13195. Epub 2019 Sep 10. J Viral Hepat. 2019. PMID: 31446638

128

Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B.

Limothai U, Chuaypen N, Poovorawan K, Poovorawan Y, Tangkijvanich P. Limothai U, et al. Among authors: tangkijvanich p. Asian Pac J Allergy Immunol. 2022 Mar;40(1):87-93. doi: 10.12932/AP-020419-0533. Asian Pac J Allergy Immunol. 2022. PMID: 31421662 Free article.

129

Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B.

Chuaypen N, Payungporn S, Poovorawan K, Chotiyaputta W, Piratvisuth T, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. Virus Genes. 2019 Oct;55(5):610-618. doi: 10.1007/s11262-019-01689-5. Epub 2019 Jul 29. Virus Genes. 2019. PMID: 31359359

130

Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals.

Chuaypen N, Tuyapala N, Pinjaroen N, Payungporn S, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. BMC Med Genet. 2019 May 22;20(1):87. doi: 10.1186/s12881-019-0823-x. BMC Med Genet. 2019. PMID: 31117968 Free PMC article.

131

The expression profile of Jagged1 and Delta-like 4 in hepatocellular carcinoma.

Kunanopparat A, Hirankarn N, Issara-Amphorn J, Tangkijvanich P, Sanpavat A. Kunanopparat A, et al. Among authors: tangkijvanich p. Asian Pac J Allergy Immunol. 2021 Mar;39(1):44-52. doi: 10.12932/AP-040818-0388. Asian Pac J Allergy Immunol. 2021. PMID: 30660174 Free article.

132

Circulating BAFF and CXCL10 levels predict response to pegylated interferon in patients with HBeAg-positive chronic hepatitis B.

Khlaiphuengsin A, Chuaypen N, Hirankarn N, Avihingsanon A, Crane M, Lewin SR, Tangkijvanich P. Khlaiphuengsin A, et al. Among authors: tangkijvanich p. Asian Pac J Allergy Immunol. 2021 Jun;39(2):129-135. doi: 10.12932/AP-050718-0365. Asian Pac J Allergy Immunol. 2021. PMID: 30660173 Free article.

133

Plasma B-cell activating factor levels and polymorphisms in hepatitis B-related hepatocellular carcinoma: Clinical correlation and prognosis.

Khlaiphuengsin A, Chuaypen N, Pinjaroen N, Sirichindakul B, Hirankarn N, Tangkijvanich P. Khlaiphuengsin A, et al. Among authors: tangkijvanich p. Asian Pac J Allergy Immunol. 2021 Jun;39(2):136-144. doi: 10.12932/AP-250718-0376. Asian Pac J Allergy Immunol. 2021. PMID: 30660167 Free article.

134

Peantum J, Kunanopparat A, Hirankarn N, Tangkijvanich P, Kimkong I. Peantum J, et al. Among authors: tangkijvanich p. Gastroenterology Res. 2018 Dec;11(6):404-410. doi: 10.14740/gr1075w. Epub 2018 Dec 17. Gastroenterology Res. 2018. PMID: 30627263 Free PMC article.

135

Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial.

Wei L, Lim SG, Xie Q, Văn KN, Piratvisuth T, Huang Y, Wu S, Xu M, Tang H, Cheng J, Le Manh H, Gao Y, Mou Z, Sobhonslidsuk A, Dou X, Thongsawat S, Nan Y, Tan CK, Ning Q, Tee HP, Mao Y, Stamm LM, Lu S, Dvory-Sobol H, Mo H, Brainard DM, Yang YF, Dao L, Wang GQ, Tanwandee T, Hu P, Tangkijvanich P, Zhang L, Gao ZL, Lin F, Le TTP, Shang J, Gong G, Li J, Su M, Duan Z, Mohamed R, Hou JL, Jia J. Wei L, et al. Among authors: tangkijvanich p. Lancet Gastroenterol Hepatol. 2019 Feb;4(2):127-134. doi: 10.1016/S2468-1253(18)30343-1. Epub 2018 Dec 14. Lancet Gastroenterol Hepatol. 2019. PMID: 30555048 Clinical Trial.

136

Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma.

Raksayot M, Chuaypen N, Khlaiphuengsin A, Pinjaroen N, Treeprasertsuk S, Poovorawan Y, Tanaka Y, Tangkijvanich P. Raksayot M, et al. Among authors: tangkijvanich p. J Gastroenterol. 2019 May;54(5):427-436. doi: 10.1007/s00535-018-01533-x. Epub 2018 Nov 30. J Gastroenterol. 2019. PMID: 30506232

137

Changes in transient elastography in early cirrhotic patients after receiving nonselective B-blocker for primary variceal bleeding prophylaxis: Three-month follow up.

Piyachaturawat P, Siramolpiwat S, Sonsiri K, Tangkijvanich P, Treeprasertsuk S. Piyachaturawat P, et al. Among authors: tangkijvanich p. JGH Open. 2018 Jul 5;2(5):172-177. doi: 10.1002/jgh3.12063. eCollection 2018 Oct. JGH Open. 2018. PMID: 30483585 Free PMC article.

138

Regulation of periostin expression by Notch signaling in hepatocytes and liver cancer cell lines.

Kongkavitoon P, Butta P, Sanpavat A, Bhattarakosol P, Tangtanatakul P, Wongprom B, Tangkijvanich P, Hirankarn N, Palaga T. Kongkavitoon P, et al. Among authors: tangkijvanich p. Biochem Biophys Res Commun. 2018 Nov 30;506(3):739-745. doi: 10.1016/j.bbrc.2018.10.144. Epub 2018 Oct 30. Biochem Biophys Res Commun. 2018. PMID: 30384995

139

Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication.

Kunanopparat A, Issara-Amphorn J, Leelahavanichkul A, Sanpavat A, Patumraj S, Tangkijvanich P, Palaga T, Hirankarn N. Kunanopparat A, et al. Among authors: tangkijvanich p. World J Gastroenterol. 2018 Sep 14;24(34):3861-3870. doi: 10.3748/wjg.v24.i34.3861. World J Gastroenterol. 2018. PMID: 30228780 Free PMC article.

140

The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono- Infection and HCV/HIV Co-Infection.

Kiatbumrung R, Chuaypen N, Payungporn S, Avihingsanon A, Tangkijvanich P. Kiatbumrung R, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2191-2197. doi: 10.22034/APJCP.2018.19.8.2191. Asian Pac J Cancer Prev. 2018. PMID: 30139224 Free PMC article.

141

Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy.

Wasitthankasem R, Vichaiwattana P, Siripon N, Posuwan N, Auphimai C, Klinfueng S, Thanetkongtong N, Vuthitanachot V, Saiyatha S, Thongmai C, Sochoo S, Sukthong P, Poovorawan K, Tangkijvanich P, Poovorawan Y. Wasitthankasem R, et al. Among authors: tangkijvanich p. PLoS One. 2018 Aug 23;13(8):e0202991. doi: 10.1371/journal.pone.0202991. eCollection 2018. PLoS One. 2018. PMID: 30138441 Free PMC article.

142

Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients.

Höner Zu Siederdissen C, Hui AJ, Sukeepaisarnjaroen W, Tangkijvanich P, Su WW, Nieto GEG, Gineste P, Nitcheu J, Crabé S, Stepien S, Manns MP, Trépo C, Wedemeyer H, Cornberg M. Höner Zu Siederdissen C, et al. Among authors: tangkijvanich p. J Infect Dis. 2018 Sep 22;218(9):1480-1484. doi: 10.1093/infdis/jiy350. J Infect Dis. 2018. PMID: 29893893 Free article. Clinical Trial.

143

Serum miR-29a and miR-122 as Potential Biomarkers for Non-Alcoholic Fatty Liver Disease (NAFLD).

Jampoka K, Muangpaisarn P, Khongnomnan K, Treeprasertsuk S, Tangkijvanich P, Payungporn S. Jampoka K, et al. Among authors: tangkijvanich p. Microrna. 2018;7(3):215-222. doi: 10.2174/2211536607666180531093302. Microrna. 2018. PMID: 29848284

144

Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein level as a diagnostic marker of hepatitis B virus-related hepatocellular carcinoma.

Chuaypen N, Chittmittraprap S, Pinjaroen N, Sirichindakul B, Poovorawan Y, Tanaka Y, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. Hepatol Res. 2018 Oct;48(11):872-881. doi: 10.1111/hepr.13187. Epub 2018 Jun 3. Hepatol Res. 2018. PMID: 29732647

145

Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study.

Wasitthankasem R, Vichaiwattana P, Siripon N, Posuwan N, Auphimai C, Klinfueng S, Thanetkongtong N, Vuthitanachot V, Saiyatha S, Thongmai C, Sochoo S, Pongsuwan N, Poovorawan K, Tangkijvanich P, Poovorawan Y. Wasitthankasem R, et al. Among authors: tangkijvanich p. PLoS One. 2018 Apr 24;13(4):e0196301. doi: 10.1371/journal.pone.0196301. eCollection 2018. PLoS One. 2018. PMID: 29689073 Free PMC article.

146

Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokinetics.

Smolders EJ, Thammajaruk N, de Kanter CTMM, Colbers A, Chaiyahong P, Cuprasitrut T, Chittmittraprap S, Apornpong T, Khemnark S, Tangkijvanich P, Burger DM, Avihingsanon A. Smolders EJ, et al. Among authors: tangkijvanich p. Trop Med Int Health. 2018 Mar;23(3):295-305. doi: 10.1111/tmi.13027. Epub 2018 Jan 10. Trop Med Int Health. 2018. PMID: 29247579 Free article.

147

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs.

Wasitthankasem R, Vichaiwattana P, Auphimai C, Siripon N, Klinfueng S, Tangkijvanich P, Vongpunsawad S, Poovorawan Y. Wasitthankasem R, et al. Among authors: tangkijvanich p. PeerJ. 2017 Nov 6;5:e4008. doi: 10.7717/peerj.4008. eCollection 2017. PeerJ. 2017. PMID: 29134150 Free PMC article.

148

Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapy.

Chuaypen N, Posuwan N, Chittmittraprap S, Hirankarn N, Treeprasertsuk S, Tanaka Y, Shinkai N, Poovorawan Y, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. Clin Microbiol Infect. 2018 Mar;24(3):306.e7-306.e13. doi: 10.1016/j.cmi.2017.07.016. Epub 2017 Jul 24. Clin Microbiol Infect. 2018. PMID: 28750917 Free article. Clinical Trial.

149

Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.

Wasitthankasem R, Vichaiwattana P, Siripon N, Posuwan N, Auphimai C, Klinfueng S, Thaneskongtong N, Vuthitanachot V, Saiyatha S, Thongmai C, Suwanpatoomlerd S, Sochoo S, Pongsuwan N, Poovorawan K, Tangkijvanich P, Vongpunsawad S, Poovorawan Y. Wasitthankasem R, et al. Among authors: tangkijvanich p. PLoS One. 2017 May 5;12(5):e0177022. doi: 10.1371/journal.pone.0177022. eCollection 2017. PLoS One. 2017. PMID: 28475637 Free PMC article.

150

Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Treeprasertsuk S, Thaimai P, Wasitthankasem R, Poovorawan Y, Komolmit P. Thanapirom K, et al. Among authors: tangkijvanich p. BMC Gastroenterol. 2017 Apr 17;17(1):54. doi: 10.1186/s12876-017-0613-x. BMC Gastroenterol. 2017. PMID: 28415985 Free PMC article.

151

Association of vitamin-D-related genetic variations and treatment response to pegylated interferon in patients with chronic hepatitis B.

Limothai U, Chuaypen N, Khlaiphuengsin A, Chittmittraprap S, Poovorawan Y, Tangkijvanich P. Limothai U, et al. Among authors: tangkijvanich p. Antivir Ther. 2017;22(8):681-688. doi: 10.3851/IMP3154. Antivir Ther. 2017. PMID: 28291736

152

Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression.

Ma-On C, Sanpavat A, Whongsiri P, Suwannasin S, Hirankarn N, Tangkijvanich P, Boonla C. Ma-On C, et al. Among authors: tangkijvanich p. Med Oncol. 2017 Apr;34(4):57. doi: 10.1007/s12032-017-0914-5. Epub 2017 Mar 9. Med Oncol. 2017. PMID: 28281193

153

Incidence and Clinical Outcome of Acute Liver Failure Caused by Dengue in a Hospital for Tropical Diseases, Thailand.

Kye Mon K, Nontprasert A, Kittitrakul C, Tangkijvanich P, Leowattana W, Poovorawan K. Kye Mon K, et al. Among authors: tangkijvanich p. Am J Trop Med Hyg. 2016 Dec 7;95(6):1338-1344. doi: 10.4269/ajtmh.16-0374. Epub 2016 Oct 17. Am J Trop Med Hyg. 2016. PMID: 27928082 Free PMC article.

154

Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.

Chuaypen N, Sriprapun M, Praianantathavorn K, Payungporn S, Wisedopas N, Poovorawan Y, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. J Med Virol. 2017 Jan;89(1):130-138. doi: 10.1002/jmv.24601. Epub 2016 Jun 21. J Med Virol. 2017. PMID: 27307409

155

Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis.

Kunanopparat A, Kimkong I, Palaga T, Tangkijvanich P, Sirichindakul B, Hirankarn N. Kunanopparat A, et al. Among authors: tangkijvanich p. World J Gastroenterol. 2016 Oct 7;22(37):8361-8374. doi: 10.3748/wjg.v22.i37.8361. World J Gastroenterol. 2016. PMID: 27729742 Free PMC article.

156

Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era.

Poovorawan K, Pan-Ngum W, White LJ, Soonthornworasiri N, Wilairatana P, Wasitthankasem R, Tangkijvanich P, Poovorawan Y. Poovorawan K, et al. Among authors: tangkijvanich p. PLoS One. 2016 Sep 15;11(9):e0163095. doi: 10.1371/journal.pone.0163095. eCollection 2016. PLoS One. 2016. PMID: 27631382 Free PMC article.

157

Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.

Sriprapun M, Chuaypen N, Khlaiphuengsin A, Pinjaroen N, Payungporn S, Tangkijvanich P. Sriprapun M, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2016;17(4):2019-25. doi: 10.7314/apjcp.2016.17.4.2019. Asian Pac J Cancer Prev. 2016. PMID: 27221889 Free article.

158

Original Research: Analysis of hepatic microRNA alterations in response to hepatitis B virus infection and pegylated interferon alpha-2a treatment.

Jinato T, Chuaypen N, Poomipak W, Praianantathavorn K, Makkoch J, Kiatbumrung R, Jampoka K, Tangkijvanich P, Payungporn S. Jinato T, et al. Among authors: tangkijvanich p. Exp Biol Med (Maywood). 2016 Oct;241(16):1803-10. doi: 10.1177/1535370216647184. Epub 2016 May 4. Exp Biol Med (Maywood). 2016. PMID: 27190255 Free PMC article.

159

Influence of Host and Viral Factors on Patients with Chronic Hepatitis C Virus Genotype 6 Treated with Pegylated Interferon and Ribavirin: A Systematic Review and Meta-Analysis.

Thong VD, Poovorawan K, Tangkijvanich P, Wasitthankasem R, Vongpunsawad S, Poovorawan Y. Thong VD, et al. Among authors: tangkijvanich p. Intervirology. 2015;58(6):373-81. doi: 10.1159/000444366. Epub 2016 Mar 25. Intervirology. 2015. PMID: 27010195

160

Autophagy machinery impaired interferon signalling pathways to benefit hepatitis B virus replication.

Kunanopparat A, Hirankarn N, Kittigul C, Tangkijvanich P, Kimkong I. Kunanopparat A, et al. Among authors: tangkijvanich p. Asian Pac J Allergy Immunol. 2016 Mar;34(1):77-85. doi: 10.12932/AP0636.34.1.2016. Asian Pac J Allergy Immunol. 2016. PMID: 26994630 Free article.

161

Genetic Variations in XRCC4 (rs1805377) and ATF6 (rs2070150) are not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection.

Makkoch J, Praianantathavorn K, Sopipong W, Chuaypen N, Tangkijvanich P, Payungporn S. Makkoch J, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2016;17(2):591-5. doi: 10.7314/apjcp.2016.17.2.591. Asian Pac J Cancer Prev. 2016. PMID: 26925648 Free article.

162

Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.

Kongkavitoon P, Tangkijvanich P, Hirankarn N, Palaga T. Kongkavitoon P, et al. Among authors: tangkijvanich p. PLoS One. 2016 Jan 14;11(1):e0146696. doi: 10.1371/journal.pone.0146696. eCollection 2016. PLoS One. 2016. PMID: 26766040 Free PMC article.

163

Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.

Chanthra N, Payungporn S, Chuaypen N, Piratanantatavorn K, Pinjaroen N, Poovorawan Y, Tangkijvanich P. Chanthra N, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2015;16(18):8405-10. doi: 10.7314/apjcp.2015.16.18.8405. Asian Pac J Cancer Prev. 2015. PMID: 26745093 Free article.

164

Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases.

Khlaiphuengsin A, Kiatbumrung R, Payungporn S, Pinjaroen N, Tangkijvanich P. Khlaiphuengsin A, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2015;16(18):8377-82. doi: 10.7314/apjcp.2015.16.18.8377. Asian Pac J Cancer Prev. 2015. PMID: 26745088 Free article.

165

Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.

Chuaypen N, Posuwan N, Payungporn S, Tanaka Y, Shinkai N, Poovorawan Y, Tangkijvanich P. Chuaypen N, et al. Among authors: tangkijvanich p. Liver Int. 2016 Jun;36(6):827-36. doi: 10.1111/liv.13046. Epub 2016 Jan 5. Liver Int. 2016. PMID: 26678018

166

Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand.

Thu AM, Poovorawan K, Kittitrakul C, Nontprasert A, Sriboonvorakul N, Phumratanaprapin W, Tangkijvanich P, Leowattana W, Wilairatana P. Thu AM, et al. Among authors: tangkijvanich p. BMC Pharmacol Toxicol. 2015 Dec 14;16:38. doi: 10.1186/s40360-015-0037-6. BMC Pharmacol Toxicol. 2015. PMID: 26651337 Free PMC article.

167

Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.

Chimparlee N, Chuaypen N, Khlaiphuengsin A, Pinjaroen N, Payungporn S, Poovorawan Y, Tangkijvanich P. Chimparlee N, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2015;16(16):7211-7. doi: 10.7314/apjcp.2015.16.16.7211. Asian Pac J Cancer Prev. 2015. PMID: 26514514 Free article.

168

Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions.

Treeprasertsuk S, Wongkarnjana A, Jaruvongvanich V, Sallapant S, Tiranathanagul K, Komolmit P, Tangkijvanich P. Treeprasertsuk S, et al. Among authors: tangkijvanich p. BMC Gastroenterol. 2015 Oct 16;15:140. doi: 10.1186/s12876-015-0372-5. BMC Gastroenterol. 2015. PMID: 26474856 Free PMC article.

169

Human miR-5193 Triggers Gene Silencing in Multiple Genotypes of Hepatitis B Virus.

Khlaiphuengsin A, T-Thienprasert NP, Tangkijvanich P, Posuwan N, Makkoch J, Poovorawan Y, Payungporn S. Khlaiphuengsin A, et al. Among authors: tangkijvanich p. Microrna. 2015;4(2):123-30. doi: 10.2174/2211536604666150819195743. Microrna. 2015. PMID: 26456535

170

Single Nucleotide Polymorphisms in miR-149 (rs2292832) and miR-101-1 (rs7536540) Are Not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection.

Pratedrat P, Sopipong W, Makkoch J, Praianantathavorn K, Chuaypen N, Tangkijvanich P, Payungporn S. Pratedrat P, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2015;16(15):6457-61. doi: 10.7314/apjcp.2015.16.15.6457. Asian Pac J Cancer Prev. 2015. PMID: 26434859 Free article.

171

A randomized clinical trial of peginterferon alpha-2b with or without entecavir in patients with HBeAg-negative chronic hepatitis B: Role of host and viral factors associated with treatment response.

Tangkijvanich P, Chittmittraprap S, Poovorawan K, Limothai U, Khlaiphuengsin A, Chuaypen N, Wisedopas N, Poovorawan Y. Tangkijvanich P, et al. J Viral Hepat. 2016 Jun;23(6):427-38. doi: 10.1111/jvh.12467. Epub 2015 Sep 21. J Viral Hepat. 2016. PMID: 26387494 Clinical Trial.

172

Association of interferon-gamma inducible protein 10 polymorphism with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B.

Limothai U, Chuaypen N, Khlaiphuengsin A, Posuwan N, Wasitthankasem R, Poovorawan Y, Tangkijvanich P. Limothai U, et al. Among authors: tangkijvanich p. Antivir Ther. 2016;21(2):97-106. doi: 10.3851/IMP2992. Epub 2015 Sep 17. Antivir Ther. 2016. PMID: 26376789

173

Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.

Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Treeprasertsuk S, Thaimai P, Wasitthankasem R, Poovorawan Y, Komolmit P. Thanapirom K, et al. Among authors: tangkijvanich p. PLoS One. 2015 Sep 4;10(9):e0137365. doi: 10.1371/journal.pone.0137365. eCollection 2015. PLoS One. 2015. PMID: 26339796 Free PMC article.

174

A molecular epidemiological study of the hepatitis B virus in Thailand after 22 years of universal immunization.

Yimnoi P, Posuwan N, Wanlapakorn N, Tangkijvanich P, Theamboonlers A, Vongpunsawad S, Poovorawan Y. Yimnoi P, et al. Among authors: tangkijvanich p. J Med Virol. 2016 Apr;88(4):664-73. doi: 10.1002/jmv.24368. Epub 2015 Sep 8. J Med Virol. 2016. PMID: 26331587

175

Single Nucleotide Polymorphism of Interferon Lambda-4 Gene is not Associated with Treatment Response to Pegylated Interferon in Thai Patients with Chronic Hepatitis B.

Limothai U, Wasitthankasem R, Poovorawan Y, Tangkijvanich P. Limothai U, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2015;16(13):5515-9. doi: 10.7314/apjcp.2015.16.13.5515. Asian Pac J Cancer Prev. 2015. PMID: 26225703 Free article.

176

Increased Oxidative Stress and RUNX3 Hypermethylation in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma (HCC) and Induction of RUNX3 Hypermethylation by Reactive Oxygen Species in HCC Cells.

Poungpairoj P, Whongsiri P, Suwannasin S, Khlaiphuengsin A, Tangkijvanich P, Boonla C. Poungpairoj P, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2015;16(13):5343-8. doi: 10.7314/apjcp.2015.16.13.5343. Asian Pac J Cancer Prev. 2015. PMID: 26225676 Free article.

177

Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.

Chanthra N, Payungporn S, Chuaypen N, Pinjaroen N, Poovorawan Y, Tangkijvanich P. Chanthra N, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2015;16(12):5069-73. doi: 10.7314/apjcp.2015.16.12.5069. Asian Pac J Cancer Prev. 2015. PMID: 26163643 Free article.

178

Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia.

Wasitthankasem R, Vongpunsawad S, Siripon N, Suya C, Chulothok P, Chaiear K, Rujirojindakul P, Kanjana S, Theamboonlers A, Tangkijvanich P, Poovorawan Y. Wasitthankasem R, et al. Among authors: tangkijvanich p. PLoS One. 2015 May 11;10(5):e0126764. doi: 10.1371/journal.pone.0126764. eCollection 2015. PLoS One. 2015. PMID: 25962112 Free PMC article.

179

Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.

Thong VD, Wasitthankasem R, Tangkijvanich P, Vongpunsawad S, Poovorawan Y. Thong VD, et al. Among authors: tangkijvanich p. PLoS One. 2015 May 4;10(5):e0125400. doi: 10.1371/journal.pone.0125400. eCollection 2015. PLoS One. 2015. PMID: 25938236 Free PMC article.

180

The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism.

Thong VD, Akkarathamrongsin S, Avihingsanon A, Theamboonlers A, Poovorawan Y, Tangkijvanich P. Thong VD, et al. Among authors: tangkijvanich p. Intervirology. 2015;58(2):73-9. doi: 10.1159/000370070. Epub 2015 Feb 13. Intervirology. 2015. PMID: 25677196

181

Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai.

Kimkong I, Chankaew J, Kunanopparat A, Hirankarn N, Tangkijvanich P. Kimkong I, et al. Among authors: tangkijvanich p. Tissue Antigens. 2015 Mar;85(3):177-81. doi: 10.1111/tan.12517. Epub 2015 Feb 9. Tissue Antigens. 2015. PMID: 25664396

182

How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.

Obach D, Yazdanpanah Y, Esmat G, Avihingsanon A, Dewedar S, Durier N, Attia A, Anwar WA, Cousien A, Tangkijvanich P, Eholié SP, Doss W, Mostafa A, Fontanet A, Mohamed MK, Deuffic-Burban S. Obach D, et al. Among authors: tangkijvanich p. Hepatology. 2015 Jul;62(1):31-9. doi: 10.1002/hep.27691. Epub 2015 Feb 27. Hepatology. 2015. PMID: 25581111

183

Early viral kinetics during hepatitis C virus genotype 6 treatment according to IL28B polymorphisms.

Akkarathamrongsin S, Payungporn S, Thong VD, Poovorawan K, Prapunwattana P, Poovorawan Y, Tangkijvanich P. Akkarathamrongsin S, et al. Among authors: tangkijvanich p. World J Gastroenterol. 2014 Aug 14;20(30):10599-605. doi: 10.3748/wjg.v20.i30.10599. World J Gastroenterol. 2014. PMID: 25132781 Free PMC article.

184

Correlation of HBsAg titers with serum fibrotic marker in patients with chronic hepatitis B infection [corrected].

Poovorawan K, Treeprasertsuk S, Tangkijvanich P, Komolmit P, Poovorawan Y. Poovorawan K, et al. Among authors: tangkijvanich p. Southeast Asian J Trop Med Public Health. 2014 May;45(3):630-5. Southeast Asian J Trop Med Public Health. 2014. PMID: 24974647

185

IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6.

Akkarathamrongsin S, Thong VD, Payungporn S, Poovorawan K, Prapunwattana P, Poovorawan Y, Tangkijvanich P. Akkarathamrongsin S, et al. Among authors: tangkijvanich p. J Med Virol. 2014 Sep;86(9):1482-90. doi: 10.1002/jmv.23957. Epub 2014 Apr 30. J Med Virol. 2014. PMID: 24782280

186

Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.

Avihingsanon A, Jitmitraparp S, Tangkijvanich P, Ramautarsing RA, Apornpong T, Jirajariyavej S, Putcharoen O, Treeprasertsuk S, Akkarathamrongsin S, Poovorawan Y, Matthews GV, Lange JM, Ruxrungtham K; HIV-NAT125 study team. Avihingsanon A, et al. Among authors: tangkijvanich p. J Gastroenterol Hepatol. 2014 Sep;29(9):1706-14. doi: 10.1111/jgh.12613. J Gastroenterol Hepatol. 2014. PMID: 24730732

187

Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.

Thong VD, Akkarathamrongsin S, Poovorawan K, Tangkijvanich P, Poovorawan Y. Thong VD, et al. Among authors: tangkijvanich p. World J Gastroenterol. 2014 Mar 21;20(11):2927-40. doi: 10.3748/wjg.v20.i11.2927. World J Gastroenterol. 2014. PMID: 24659883 Free PMC article. Review.

188

Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy.

Crane M, Avihingsanon A, Rajasuriar R, Velayudham P, Iser D, Solomon A, Sebolao B, Tran A, Spelman T, Matthews G, Cameron P, Tangkijvanich P, Dore GJ, Ruxrungtham K, Lewin SR. Crane M, et al. Among authors: tangkijvanich p. J Infect Dis. 2014 Sep 1;210(5):745-51. doi: 10.1093/infdis/jiu119. Epub 2014 Feb 28. J Infect Dis. 2014. PMID: 24585898

189

Genetic association of human leukocyte antigens with chronicity or resolution of hepatitis B infection in thai population.

Posuwan N, Payungporn S, Tangkijvanich P, Ogawa S, Murakami S, Iijima S, Matsuura K, Shinkai N, Watanabe T, Poovorawan Y, Tanaka Y. Posuwan N, et al. Among authors: tangkijvanich p. PLoS One. 2014 Jan 23;9(1):e86007. doi: 10.1371/journal.pone.0086007. eCollection 2014. PLoS One. 2014. PMID: 24465836 Free PMC article.

190

Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).

Chittmittrapap S, Chieochansin T, Chaiteerakij R, Treeprasertsuk S, Klaikaew N, Tangkijvanich P, Komolmit P, Poovorawan Y. Chittmittrapap S, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2013;14(12):7675-9. doi: 10.7314/apjcp.2013.14.12.7675. Asian Pac J Cancer Prev. 2013. PMID: 24460352 Free article.

191

Circulating cytokines and histological liver damage in chronic hepatitis B infection.

Poovorawan K, Tangkijvanich P, Chirathaworn C, Wisedopas N, Treeprasertsuk S, Komolmit P, Poovorawan Y. Poovorawan K, et al. Among authors: tangkijvanich p. Hepat Res Treat. 2013;2013:757246. doi: 10.1155/2013/757246. Epub 2013 Oct 31. Hepat Res Treat. 2013. PMID: 24288603 Free PMC article.

192

Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy.

Avihingsanon A, Apornpong T, Ramautarsing RA, Ubolyam S, Tangkijvanich P, Ananworanich J, Lange JM, Matthews G, Lewin SR, Ruxrungtham K; HIV-NAT 105 study team. Avihingsanon A, et al. Among authors: tangkijvanich p. Antivir Ther. 2014;19(1):41-9. doi: 10.3851/IMP2673. Epub 2013 Aug 23. Antivir Ther. 2014. PMID: 23970149

193

Serum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b.

Kuakarn S, SomParn P, Tangkijvanich P, Mahachai V, Thongboonkerd V, Hirankarn N. Kuakarn S, et al. Among authors: tangkijvanich p. World J Gastroenterol. 2013 Aug 21;19(31):5067-75. doi: 10.3748/wjg.v19.i31.5067. World J Gastroenterol. 2013. PMID: 23964140 Free PMC article.

194

Comparison of long-term outcome of patients with Wilson's disease presenting with acute liver failure versus acute-on-chronic liver failure.

Thanapirom K, Treeprasertsuk S, Komolmit P, Tangkijvanich P, Kullavanijaya P. Thanapirom K, et al. Among authors: tangkijvanich p. J Med Assoc Thai. 2013 Feb;96(2):150-6. J Med Assoc Thai. 2013. PMID: 23936979

195

Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand.

Thongbai C, Sa-nguanmoo P, Kranokpiruk P, Poovorawan K, Poovorawan Y, Tangkijvanich P. Thongbai C, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2013;14(6):3555-9. doi: 10.7314/apjcp.2013.14.6.3555. Asian Pac J Cancer Prev. 2013. PMID: 23886144 Free article.

196

Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection.

Chalermchai T, Hiransuthikul N, Tangkijvanich P, Pinyakorn S, Avihingsanon A, Ananworanich J. Chalermchai T, et al. Among authors: tangkijvanich p. AIDS Res Ther. 2013 Jul 26;10:21. doi: 10.1186/1742-6405-10-21. eCollection 2013. AIDS Res Ther. 2013. PMID: 23885958 Free PMC article.

197

Molecular epidemiology and genetic history of hepatitis C virus subtype 3a infection in Thailand.

Akkarathamrongsin S, Hacharoen P, Tangkijvanich P, Theamboonlers A, Tanaka Y, Mizokami M, Poovorawan Y. Akkarathamrongsin S, et al. Among authors: tangkijvanich p. Intervirology. 2013;56(5):284-94. doi: 10.1159/000351621. Epub 2013 Jul 3. Intervirology. 2013. PMID: 23838334

198

The KIF1B (rs17401966) single nucleotide polymorphism is not associated with the development of HBV-related hepatocellular carcinoma in Thai patients.

Sopipong W, Tangkijvanich P, Payungporn S, Posuwan N, Poovorawan Y. Sopipong W, et al. Among authors: tangkijvanich p. Asian Pac J Cancer Prev. 2013;14(5):2865-9. doi: 10.7314/apjcp.2013.14.5.2865. Asian Pac J Cancer Prev. 2013. PMID: 23803045 Free article.

199

Association of IFNAR2 and IL10RB genes in chronic hepatitis B virus infection.

Romporn S, Hirankarn N, Tangkijvanich P, Kimkong I. Romporn S, et al. Among authors: tangkijvanich p. Tissue Antigens. 2013 Jul;82(1):21-5. doi: 10.1111/tan.12133. Tissue Antigens. 2013. PMID: 23745570

200

Association of interferon-alpha gene polymorphisms with chronic hepatitis B virus infection.

Kimkong I, Tangkijvanich P, Hirankarn N. Kimkong I, et al. Among authors: tangkijvanich p. Int J Immunogenet. 2013 Dec;40(6):476-81. doi: 10.1111/iji.12055. Epub 2013 Apr 8. Int J Immunogenet. 2013. PMID: 23566196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters